<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36077049</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>12</Day></DateCompleted><DateRevised><Year>2022</Year><Month>09</Month><Day>22</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>17</Issue><PubDate><Year>2022</Year><Month>Aug</Month><Day>25</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Downstream Effects of Mutations in <i>SOD1</i> and <i>TARDBP</i> Converge on Gene Expression Impairment in Patient-Derived Motor Neurons.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">9652</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms23179652</ELocationID><Abstract><AbstractText>Amyotrophic Lateral Sclerosis (ALS) is a progressive and fatal neurodegenerative disease marked by death of motor neurons (MNs) present in the spinal cord, brain stem and motor cortex. Despite extensive research, the reason for neurodegeneration is still not understood. To generate novel hypotheses of putative underlying molecular mechanisms, we used human induced pluripotent stem cell (hiPSCs)-derived motor neurons (MNs) from <i>SOD1</i>- and <i>TARDBP</i> (TDP-43 protein)-mutant-ALS patients and healthy controls to perform high-throughput RNA-sequencing (RNA-Seq). An integrated bioinformatics approach was employed to identify differentially expressed genes (DEGs) and key pathways underlying these familial forms of the disease (fALS). In TDP43-ALS, we found dysregulation of transcripts encoding components of the transcriptional machinery and transcripts involved in splicing regulation were particularly affected. In contrast, less is known about the role of SOD1 in RNA metabolism in motor neurons. Here, we found that many transcripts relevant for mitochondrial function were specifically altered in SOD1-ALS, indicating that transcriptional signatures and expression patterns can vary significantly depending on the causal gene that is mutated. Surprisingly, however, we identified a clear downregulation of genes involved in protein translation in SOD1-ALS suggesting that ALS-causing SOD1 mutations shift cellular RNA abundance profiles to cause neural dysfunction. Altogether, we provided here an extensive profiling of mRNA expression in two ALS models at the cellular level, corroborating the major role of RNA metabolism and gene expression as a common pathomechanism in ALS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dash</LastName><ForeName>Banaja P</ForeName><Initials>BP</Initials><Identifier Source="ORCID">0000-0003-4580-139X</Identifier><AffiliationInfo><Affiliation>Translational Neurodegeneration Section "Albrecht-Kossel", Department of Neurology, University Medical Center Rostock, 18147 Rostock, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Freischmidt</LastName><ForeName>Axel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, Ulm University, 89081 Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weishaupt</LastName><ForeName>Jochen H</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Division of Neurodegeneration, Department of Neurology, Mannheim Center for Translational Neurosciences, Medical Faculty Mannheim, Heidelberg University, 68167 Mannheim, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hermann</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-7364-7791</Identifier><AffiliationInfo><Affiliation>Translational Neurodegeneration Section "Albrecht-Kossel", Department of Neurology, University Medical Center Rostock, 18147 Rostock, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Transdisciplinary Neurosciences Rostock, University Medical Center Rostock, 18147 Rostock, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Deutsches Zentrum f&#xfc;r Neurodegenerative Erkrankungen (DZNE) Rostock/Greifswald, 18147 Rostock, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000606290">SOD1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000598624">TARDBP protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>63231-63-0</RegistryNumber><NameOfSubstance UI="D012313">RNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015870" MajorTopicYN="N">Gene Expression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057026" MajorTopicYN="Y">Induced Pluripotent Stem Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="Y">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012313" MajorTopicYN="N">RNA</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">RNA sequencing (RNA-Seq)</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis (ALS)</Keyword><Keyword MajorTopicYN="N">differentially expressed genes (DEG)</Keyword><Keyword MajorTopicYN="N">human induced pluripotent stem cells (iPSC)</Keyword><Keyword MajorTopicYN="N">motor neurons (MN)</Keyword><Keyword MajorTopicYN="N">protein-protein interaction (PPI)</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>8</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>9</Day><Hour>1</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36077049</ArticleId><ArticleId IdType="pmc">PMC9456253</ArticleId><ArticleId IdType="doi">10.3390/ijms23179652</ArticleId><ArticleId IdType="pii">ijms23179652</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Peters O.M., Ghasemi M., Brown R.H., Jr. Emerging mechanisms of molecular pathology in ALS Find the latest version: Emerging mechanisms of molecular pathology in ALS. J. Clin. Investig. 2015;125:1767&#x2013;1779. doi: 10.1172/JCI71601.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI71601</ArticleId><ArticleId IdType="pmc">PMC4463186</ArticleId><ArticleId IdType="pubmed">25932674</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia R., Chi&#xf2; A., Traynor B.J. Novel genes associated with amyotrophic lateral sclerosis: Diagnostic and clinical implications. Lancet Neurol. 2018;17:94&#x2013;102. doi: 10.1016/S1474-4422(17)30401-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30401-5</ArticleId><ArticleId IdType="pmc">PMC5901717</ArticleId><ArticleId IdType="pubmed">29154141</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen H.P., Van Broeckhoven C., van der Zee J. ALS Genes in the Genomic Era and their Implications for FTD. Trends Genet. 2018;34:404&#x2013;423. doi: 10.1016/j.tig.2018.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tig.2018.03.001</ArticleId><ArticleId IdType="pubmed">29605155</ArticleId></ArticleIdList></Reference><Reference><Citation>Magran&#xe9; J., Cortez C., Gan W.B., Manfredi G. Abnormal mitochondrial transport and morphology are common pathological denominators in SOD1 and TDP43 ALS mouse models. Hum. Mol. Genet. 2014;23:1413&#x2013;1424. doi: 10.1093/hmg/ddt528.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt528</ArticleId><ArticleId IdType="pmc">PMC3929084</ArticleId><ArticleId IdType="pubmed">24154542</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti E., Baralle F.E. The multiple roles of TDP-43 in pre-mRNA processing and gene expression regulation. RNA Biol. 2010;7:420&#x2013;429. doi: 10.4161/rna.7.4.12205.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/rna.7.4.12205</ArticleId><ArticleId IdType="pubmed">20639693</ArticleId></ArticleIdList></Reference><Reference><Citation>De Vos K.J., Hafezparast M. Neurobiology of axonal transport defects in motor neuron diseases: Opportunities for translational research? Neurobiol. Dis. 2017;105:283&#x2013;299. doi: 10.1016/j.nbd.2017.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2017.02.004</ArticleId><ArticleId IdType="pmc">PMC5536153</ArticleId><ArticleId IdType="pubmed">28235672</ArticleId></ArticleIdList></Reference><Reference><Citation>Briese M., Saal-Bauernschubert L., L&#xfc;ningschr&#xf6;r P., Moradi M., Dombert B., Surrey V., Appenzeller S., Deng C., Jablonka S., Sendtner M. Loss of Tdp-43 disrupts the axonal transcriptome of motoneurons accompanied by impaired axonal translation and mitochondria function. Acta Neuropathol. Commun. 2020;8:116. doi: 10.1186/s40478-020-00987-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-020-00987-6</ArticleId><ArticleId IdType="pmc">PMC7379803</ArticleId><ArticleId IdType="pubmed">32709255</ArticleId></ArticleIdList></Reference><Reference><Citation>Saxena S., Cabuy E., Caroni P. A role for motoneuron subtype-selective ER stress in disease manifestations of FALS mice. Nat. Neurosci. 2009;12:627&#x2013;636. doi: 10.1038/nn.2297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2297</ArticleId><ArticleId IdType="pubmed">19330001</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W., Li L., Lin W.L., Dickson D.W., Petrucelli L., Zhang T., Wang X. The ALS disease-associated mutant TDP-43 impairs mitochondrial dynamics and function in motor neurons. Hum. Mol. Genet. 2013;22:4706&#x2013;4719. doi: 10.1093/hmg/ddt319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt319</ArticleId><ArticleId IdType="pmc">PMC3820133</ArticleId><ArticleId IdType="pubmed">23827948</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffman E.K., Wilcox H.M., Scott R.W., Siman R. Proteasome inhibition enhances the stability of mouse Cu/Zn superoxide dismutase with mutations linked to familial amyotrophic lateral sclerosis. J. Neurol. Sci. 1996;139:15&#x2013;20. doi: 10.1016/0022-510X(96)00031-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-510X(96)00031-7</ArticleId><ArticleId IdType="pubmed">8836967</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamas N.J., Roybon L. Harnessing the Potential of Human Pluripotent Stem Cell-Derived Motor Neurons for Drug Discovery in Amyotrophic Lateral Sclerosis: From the Clinic to the Laboratory and Back to the Patient. Front. Drug Discov. 2021;1:1&#x2013;26. doi: 10.3389/fddsv.2021.773424.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fddsv.2021.773424</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown R.H., Al-Chalabi A. Amyotrophic lateral sclerosis. N. Engl. J. Med. 2017;377:162&#x2013;172. doi: 10.1056/NEJMra1603471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Serio A., Bilican B., Barmada S.J., Ando D.M., Zhao C., Siller R., Burr K., Haghi G., Story D., Nishimura A.L., et al. Astrocyte pathology and the absence of non-cell autonomy in an induced pluripotent stem cell model of TDP-43 proteinopathy. Proc. Natl. Acad. Sci. USA. 2013;110:4697&#x2013;4702. doi: 10.1073/pnas.1300398110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1300398110</ArticleId><ArticleId IdType="pmc">PMC3607024</ArticleId><ArticleId IdType="pubmed">23401527</ArticleId></ArticleIdList></Reference><Reference><Citation>Wada T., Goparaju S.K., Tooi N., Inoue H., Takahashi R., Nakatsuji N., Aiba K. Amyotrophic Lateral Sclerosis Model Derived from Human Embryonic Stem Cells Overexpressing Mutant Superoxide Dismutase 1. Stem Cells Transl. Med. 2012;1:396&#x2013;402. doi: 10.5966/sctm.2011-0061.</Citation><ArticleIdList><ArticleId IdType="doi">10.5966/sctm.2011-0061</ArticleId><ArticleId IdType="pmc">PMC3659703</ArticleId><ArticleId IdType="pubmed">23197818</ArticleId></ArticleIdList></Reference><Reference><Citation>Dash B.P., Naumann M., Sterneckert J., Hermann A. Genome wide analysis points towards subtype-specific diseases in different genetic forms of amyotrophic lateral sclerosis. Int. J. Mol. Sci. 2020;21:6938. doi: 10.3390/ijms21186938.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21186938</ArticleId><ArticleId IdType="pmc">PMC7555318</ArticleId><ArticleId IdType="pubmed">32967368</ArticleId></ArticleIdList></Reference><Reference><Citation>Heath P.R., Kirby J., Shaw P.J. Investigating cell death mechanisms in amyotrophic lateral sclerosis using transcriptomics. Front. Cell. Neurosci. 2013;7:259. doi: 10.3389/fncel.2013.00259.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2013.00259</ArticleId><ArticleId IdType="pmc">PMC3865770</ArticleId><ArticleId IdType="pubmed">24381542</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper-Knock J., Kirby J., Ferraiuolo L., Heath P.R., Rattray M., Shaw P.J. Gene expression profiling in human neurodegenerative disease. Nat. Rev. Neurol. 2012;8:518&#x2013;530. doi: 10.1038/nrneurol.2012.156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2012.156</ArticleId><ArticleId IdType="pubmed">22890216</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferraiuolo L., Kirby J., Grierson A.J., Sendtner M., Shaw P.J. Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis. Nat. Rev. Neurol. 2011;7:616&#x2013;630. doi: 10.1038/nrneurol.2011.152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2011.152</ArticleId><ArticleId IdType="pubmed">22051914</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Beltr&#xe1;n L.C., Godoy-Corchuelo J.M., Losa-Fontangordo M., Williams D., Matias-Guiu J., Corrochano S. A transcriptomic meta-analysis shows lipid metabolism dysregulation as an early pathological mechanism in the spinal cord of sod1 mice. Int. J. Mol. Sci. 2021;22:9553. doi: 10.3390/ijms22179553.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22179553</ArticleId><ArticleId IdType="pmc">PMC8431303</ArticleId><ArticleId IdType="pubmed">34502460</ArticleId></ArticleIdList></Reference><Reference><Citation>Butti Z., Patten S.A. RNA dysregulation in amyotrophic lateral sclerosis. Front. Genet. 2019;9:712. doi: 10.3389/fgene.2018.00712.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2018.00712</ArticleId><ArticleId IdType="pmc">PMC6349704</ArticleId><ArticleId IdType="pubmed">30723494</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehmkuhl E.M., Zarnescu D.C. Lost in translation: Evidence for protein synthesis deficits in ALS/FTD and related neurodegenerative diseases. Adv. Neurobiol. 2018;20:283&#x2013;301. doi: 10.1007/978-3-319-89689-2_11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-319-89689-2_11</ArticleId><ArticleId IdType="pmc">PMC6530776</ArticleId><ArticleId IdType="pubmed">29916024</ArticleId></ArticleIdList></Reference><Reference><Citation>Polymenidou M., Lagier-Tourenne C., Hutt K.R., Bennett C.F., Cleveland D.W., Yeo G.W. Misregulated RNA processing in amyotrophic lateral sclerosis. Brain Res. 2012;1462:3&#x2013;15. doi: 10.1016/j.brainres.2012.02.059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2012.02.059</ArticleId><ArticleId IdType="pmc">PMC3707312</ArticleId><ArticleId IdType="pubmed">22444279</ArticleId></ArticleIdList></Reference><Reference><Citation>Barmada S.J. Linking RNA Dysfunction and Neurodegeneration in Amyotrophic Lateral Sclerosis. Neurotherapeutics. 2015;12:340&#x2013;351. doi: 10.1007/s13311-015-0340-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-015-0340-3</ArticleId><ArticleId IdType="pmc">PMC4404431</ArticleId><ArticleId IdType="pubmed">25689976</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor J.P., Brown R.H., Cleveland D.W. Decoding ALS: From genes to mechanism. Nature. 2016;539:197&#x2013;206. doi: 10.1038/nature20413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20413</ArticleId><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratti A., Buratti E. Physiological functions and pathobiology of TDP-43 and FUS/TLS proteins. J. Neurochem. 2016;138:95&#x2013;111. doi: 10.1111/jnc.13625.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.13625</ArticleId><ArticleId IdType="pubmed">27015757</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen T.J., Lee V.M.Y., Trojanowski J.Q. TDP-43 functions and pathogenic mechanisms implicated in TDP-43 proteinopathies. Trends Mol. Med. 2011;17:659&#x2013;667. doi: 10.1016/j.molmed.2011.06.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2011.06.004</ArticleId><ArticleId IdType="pmc">PMC3202652</ArticleId><ArticleId IdType="pubmed">21783422</ArticleId></ArticleIdList></Reference><Reference><Citation>Tollervey J.R., Curk T., Rogelj B., Briese M., Cereda M., Kayikci M., K&#xf6;nig J., Hortob&#xe1;gyi T., Nishimura A.L., &#x17d;upunski V., et al. Characterizing the RNA targets and position-dependent splicing regulation by TDP-43. Nat. Neurosci. 2011;14:452&#x2013;458. doi: 10.1038/nn.2778.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2778</ArticleId><ArticleId IdType="pmc">PMC3108889</ArticleId><ArticleId IdType="pubmed">21358640</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling S.C., Polymenidou M., Cleveland D.W. Converging mechanisms in als and FTD: Disrupted RNA and protein homeostasis. Neuron. 2013;79:416&#x2013;438. doi: 10.1016/j.neuron.2013.07.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.07.033</ArticleId><ArticleId IdType="pmc">PMC4411085</ArticleId><ArticleId IdType="pubmed">23931993</ArticleId></ArticleIdList></Reference><Reference><Citation>Conlon E.G., Fagegaltier D., Agius P., Davis-Porada J., Gregory J., Hubbard I., Kang K., Kim D., Phatnani H., Shneider N.A., et al. Unexpected similarities between C9ORF72 and sporadic forms of ALS/FTD suggest a common disease mechanism. Elife. 2018;7:e37754. doi: 10.7554/eLife.37754.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.37754</ArticleId><ArticleId IdType="pmc">PMC6103746</ArticleId><ArticleId IdType="pubmed">30003873</ArticleId></ArticleIdList></Reference><Reference><Citation>Bandyopadhyay U., Cotney J., Nagy M., Oh S., Leng J., Mahajan M., Mane S., Fenton W.A., Noonan J.P., Horwich A.L. RNA-Seq Profiling of Spinal Cord Motor Neurons from a Presymptomatic SOD1 ALS Mouse. PLoS ONE. 2013;8:e53575. doi: 10.1371/journal.pone.0053575.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0053575</ArticleId><ArticleId IdType="pmc">PMC3536741</ArticleId><ArticleId IdType="pubmed">23301088</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney M.E., Pu H., Chiu A.Y., Dal Canto M.C., Polchow C.Y., Alexander D.D., Caliendo J., Hentati A., Kwon Y.W., Deng H.X., et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science. 1994;264:1772&#x2013;1775. doi: 10.1126/science.8209258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8209258</ArticleId><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Strong M.J. The evidence for altered RNA metabolism in amyotrophic lateral sclerosis (ALS) J. Neurol. Sci. 2010;288:1&#x2013;12. doi: 10.1016/j.jns.2009.09.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2009.09.029</ArticleId><ArticleId IdType="pubmed">19840884</ArticleId></ArticleIdList></Reference><Reference><Citation>Spaulding E.L., Burgess R.W. Accumulating evidence for axonal translation in neuronal homeostasis. Front. Neurosci. 2017;11:312. doi: 10.3389/fnins.2017.00312.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2017.00312</ArticleId><ArticleId IdType="pmc">PMC5450000</ArticleId><ArticleId IdType="pubmed">28620277</ArticleId></ArticleIdList></Reference><Reference><Citation>Xing L., Bassell G.J. MRNA localization: An orchestration of assembly, traffic and synthesis. Traffic. 2012;14:2&#x2013;14. doi: 10.1111/tra.12004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tra.12004</ArticleId><ArticleId IdType="pmc">PMC3548013</ArticleId><ArticleId IdType="pubmed">22913533</ArticleId></ArticleIdList></Reference><Reference><Citation>Verheijen M.H.G., Peviani M., Hendricusdottir R., Bell E.M., Lammens M., Smit A.B., Bendotti C., Van Minnen J. Increased axonal ribosome numbers is an early event in the pathogenesis of amyotrophic lateral sclerosis. PLoS ONE. 2014;9:e87255. doi: 10.1371/journal.pone.0087255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0087255</ArticleId><ArticleId IdType="pmc">PMC3907527</ArticleId><ArticleId IdType="pubmed">24498056</ArticleId></ArticleIdList></Reference><Reference><Citation>Riva N., Clarelli F., Domi T., Cerri F., Gallia F., Trimarco A., Brambilla P., Lunetta C., Lazzerini A., Lauria G., et al. Unraveling gene expression profiles in peripheral motor nerve from amyotrophic lateral sclerosis patients: Insights into pathogenesis. Sci. Rep. 2016;6:39297. doi: 10.1038/srep39297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep39297</ArticleId><ArticleId IdType="pmc">PMC5159906</ArticleId><ArticleId IdType="pubmed">27982123</ArticleId></ArticleIdList></Reference><Reference><Citation>Briese M., Saal L., Appenzeller S., Moradi M., Baluapuri A., Sendtner M. Whole transcriptome profiling reveals the RNA content of motor axons. Nucleic Acids Res. 2015;44:e33. doi: 10.1093/nar/gkv1027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkv1027</ArticleId><ArticleId IdType="pmc">PMC4770199</ArticleId><ArticleId IdType="pubmed">26464439</ArticleId></ArticleIdList></Reference><Reference><Citation>Rotem N., Magen I., Ionescu A., Gershoni-Emek N., Altman T., Costa C.J., Gradus T., Pasmanik-Chor M., Willis D.E., Ben-Dov I.Z., et al. ALS along the Axons-Expression of coding and noncoding RNA differs in axons of ALS models. Sci. Rep. 2017;7:44500. doi: 10.1038/srep44500.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep44500</ArticleId><ArticleId IdType="pmc">PMC5353576</ArticleId><ArticleId IdType="pubmed">28300211</ArticleId></ArticleIdList></Reference><Reference><Citation>Nijssen J., Aguila J., Hoogstraaten R., Kee N., Hedlund E. Axon-Seq Decodes the Motor Axon Transcriptome and Its Modulation in Response to ALS. Stem Cell Rep. 2018;11:1565&#x2013;1578. doi: 10.1016/j.stemcr.2018.11.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2018.11.005</ArticleId><ArticleId IdType="pmc">PMC6294264</ArticleId><ArticleId IdType="pubmed">30540963</ArticleId></ArticleIdList></Reference><Reference><Citation>Namboori S.C., Thomas P., Ames R., Hawkins S., Garrett L.O., Willis C.R.G., Rosa A., Stanton L.W., Bhinge A. Single-cell transcriptomics identifies master regulators of neurodegeneration in SOD1 ALS iPSC-derived motor neurons. Stem Cell Rep. 2021;16:3020&#x2013;3035. doi: 10.1016/j.stemcr.2021.10.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2021.10.010</ArticleId><ArticleId IdType="pmc">PMC8693652</ArticleId><ArticleId IdType="pubmed">34767750</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen P.M., Forsgren L., Binzer M., Nilsson P., Ala-Hurula V., Ker&#xe4;nen M.L., Bergmark L., Saarinen A., Haltia T., Tarvainen I., et al. Autosomal recessive adult-onset amyohophic lateral sclerosis associated with homozygosity for Asp90A1a CuZn-superoxide dismutase mutation A clinical and genealogical study of 36 patients. Brain. 1996;119:1153&#x2013;1172. doi: 10.1093/brain/119.4.1153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/119.4.1153</ArticleId><ArticleId IdType="pubmed">8813280</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xfc;nther R., Pal A., Williams C., Zimyanin V.L., Liehr M., von Neubeck C., Krause M., Parab M.G., Petri S., Kalmbach N., et al. Alteration of Mitochondrial Integrity as Upstream Event in the Pathophysiology of SOD1-ALS. Cells. 2022;11:1246. doi: 10.3390/cells11071246.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11071246</ArticleId><ArticleId IdType="pmc">PMC8997900</ArticleId><ArticleId IdType="pubmed">35406813</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinhardt P., Glatza M., Hemmer K., Tsytsyura Y., Thiel C.S., H&#xf6;ing S., Moritz S., Parga J.A., Wagner L., Bruder J.M., et al. Derivation and Expansion Using Only Small Molecules of Human Neural Progenitors for Neurodegenerative Disease Modeling. PLoS ONE. 2013;8:e59252. doi: 10.1371/annotation/6a917a2e-df4a-4ad9-99bb-6aa7218b833e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/annotation/6a917a2e-df4a-4ad9-99bb-6aa7218b833e</ArticleId><ArticleId IdType="pmc">PMC3606479</ArticleId><ArticleId IdType="pubmed">23533608</ArticleId></ArticleIdList></Reference><Reference><Citation>Bursch F., Kalmbach N., Naujock M., Staege S., Eggenschwiler R., Abo-Rady M., Japtok J., Guo W., Hensel N., Reinhardt P., et al. Altered calcium dynamics and glutamate receptor properties in iPSC-derived motor neurons from ALS patients with C9orf72, FUS, SOD1 or TDP43 mutations. Hum. Mol. Genet. 2019;28:2835&#x2013;2850. doi: 10.1093/hmg/ddz107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddz107</ArticleId><ArticleId IdType="pubmed">31108504</ArticleId></ArticleIdList></Reference><Reference><Citation>Naumann M., Pal A., Goswami A., Lojewski X., Japtok J., Vehlow A., Naujock M., G&#xfc;nther R., Jin M., Stanslowsky N., et al. Impaired DNA damage response signaling by FUS-NLS mutations leads to neurodegeneration and FUS aggregate formation. Nat. Commun. 2018;9:335. doi: 10.1038/s41467-017-02299-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-02299-1</ArticleId><ArticleId IdType="pmc">PMC5780468</ArticleId><ArticleId IdType="pubmed">29362359</ArticleId></ArticleIdList></Reference><Reference><Citation>Naujock M., Stanslowsky N., Bufler S., Naumann M., Reinhardt P., Sterneckert J., Petri S. 4-aminopyridine induced activity rescues hypoexcitable Motor Neurons from Amyotrophic Lateral Sclerosis Patient-Derived Induced. Stem Cells. 2016;34:1563&#x2013;1575. doi: 10.1002/stem.2354.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/stem.2354</ArticleId><ArticleId IdType="pubmed">26946488</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreiter N., Pal A., Lojewski X., Corcia P., Naujock M., Reinhardt P., Sterneckert J., Petri S., Wegner F., Storch A., et al. Age-dependent neurodegeneration and organelle transport deficiencies in mutant TDP43 patient-derived neurons are independent of TDP43 aggregation. Neurobiol. Dis. 2018;115:167&#x2013;181. doi: 10.1016/j.nbd.2018.03.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2018.03.010</ArticleId><ArticleId IdType="pubmed">29630989</ArticleId></ArticleIdList></Reference><Reference><Citation>Szklarczyk D., Gable A.L., Lyon D., Junge A., Wyder S., Huerta-Cepas J., Simonovic M., Doncheva N.T., Morris J.H., Bork P., et al. STRING v11: Protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47:D607&#x2013;D613. doi: 10.1093/nar/gky1131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky1131</ArticleId><ArticleId IdType="pmc">PMC6323986</ArticleId><ArticleId IdType="pubmed">30476243</ArticleId></ArticleIdList></Reference><Reference><Citation>Smoot M.E., Ono K., Ruscheinski J., Wang P.L., Ideker T. Cytoscape 2.8: New features for data integration and network visualization. Bioinformatics. 2010;27:431&#x2013;432. doi: 10.1093/bioinformatics/btq675.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btq675</ArticleId><ArticleId IdType="pmc">PMC3031041</ArticleId><ArticleId IdType="pubmed">21149340</ArticleId></ArticleIdList></Reference><Reference><Citation>Bader G.D., Hogue C.W.V. An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinformatics. 2003;4:2&#x2013;27. doi: 10.1186/1471-2105-4-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-4-2</ArticleId><ArticleId IdType="pmc">PMC149346</ArticleId><ArticleId IdType="pubmed">12525261</ArticleId></ArticleIdList></Reference><Reference><Citation>Bindea G., Mlecnik B., Hackl H., Charoentong P., Tosolini M., Kirilovsky A., Fridman W.H., Pag&#xe8;s F., Trajanoski Z., Galon J. ClueGO: A Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics. 2009;25:1091&#x2013;1093. doi: 10.1093/bioinformatics/btp101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btp101</ArticleId><ArticleId IdType="pmc">PMC2666812</ArticleId><ArticleId IdType="pubmed">19237447</ArticleId></ArticleIdList></Reference><Reference><Citation>Bindea G., Galon J., Mlecnik B. CluePedia Cytoscape plugin: Pathway insights using integrated experimental and in silico data. Bioinformatics. 2013;29:661&#x2013;663. doi: 10.1093/bioinformatics/btt019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btt019</ArticleId><ArticleId IdType="pmc">PMC3582273</ArticleId><ArticleId IdType="pubmed">23325622</ArticleId></ArticleIdList></Reference><Reference><Citation>Chin C.H., Chen S.H., Wu H.H., Ho C.W., Ko M.T., Lin C.Y. cytoHubba: Identifying hub objects and sub-networks from complex interactome. BMC Syst. Biol. 2014;8((Suppl. 4)):S11. doi: 10.1186/1752-0509-8-S4-S11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1752-0509-8-S4-S11</ArticleId><ArticleId IdType="pmc">PMC4290687</ArticleId><ArticleId IdType="pubmed">25521941</ArticleId></ArticleIdList></Reference><Reference><Citation>Robberecht W., Philips T. The changing scene of amyotrophic lateral sclerosis. Nat. Rev. Neurosci. 2013;14:248&#x2013;264.</Citation><ArticleIdList><ArticleId IdType="pubmed">23463272</ArticleId></ArticleIdList></Reference><Reference><Citation>Tcherkezian J., Brittis P.A., Thomas F., Roux P.P., Flanagan J.G. Transmembrane Receptor DCC Associates with Protein Synthesis Machinery and Regulates Translation. Cell. 2010;141:632&#x2013;644. doi: 10.1016/j.cell.2010.04.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2010.04.008</ArticleId><ArticleId IdType="pmc">PMC2881594</ArticleId><ArticleId IdType="pubmed">20434207</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagano S., Jinno J., Abdelhamid R.F., Jin Y., Shibata M., Watanabe S., Hirokawa S., Nishizawa M., Sakimura K., Onodera O., et al. TDP-43 transports ribosomal protein mRNA to regulate axonal local translation in neuronal axons. Acta Neuropathol. 2020;140:695&#x2013;713. doi: 10.1007/s00401-020-02205-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-020-02205-y</ArticleId><ArticleId IdType="pubmed">32803350</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J.X., Wang Y., Zhang Y.J., Shen M.F., Li H.Y., Yu Z.Q., Chen G. Axonal mRNA localization and local translation in neurodegenerative disease. Neural Regen. Res. 2021;16:1950&#x2013;1957.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8343310</ArticleId><ArticleId IdType="pubmed">33642365</ArticleId></ArticleIdList></Reference><Reference><Citation>Cestra G., Rossi S., Di Salvio M., Cozzolino M. Control of mRNA translation in ALS proteinopathy. Front. Mol. Neurosci. 2017;10:85. doi: 10.3389/fnmol.2017.00085.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00085</ArticleId><ArticleId IdType="pmc">PMC5362592</ArticleId><ArticleId IdType="pubmed">28386218</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirby J., Halligan E., Baptista M.J., Allen S., Heath P.R., Holden H., Barber S.C., Loynes C.A., Wood-Allum C.A., Lunec J., et al. Mutant SOD1 alters the motor neuronal transcriptome: Implications for familial ALS. Brain. 2005;128:1686&#x2013;1706. doi: 10.1093/brain/awh503.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awh503</ArticleId><ArticleId IdType="pubmed">15872021</ArticleId></ArticleIdList></Reference><Reference><Citation>Hedlund E., Karlsson M., Osborn T., Ludwig W., Isacson O. Global gene expression profiling of somatic motor neuron populations with different vulnerability identify molecules and pathways of degeneration and protection. Brain. 2010;133:2313&#x2013;2330. doi: 10.1093/brain/awq167.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awq167</ArticleId><ArticleId IdType="pmc">PMC3139939</ArticleId><ArticleId IdType="pubmed">20826431</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumimoto E.L., Fore T.R., Zhang B. Transcriptome profiling following neuronal and glial expression of ALS-linked SOD1 in drosophila. G3 Genes Genomes Genet. 2013;3:695&#x2013;708. doi: 10.1534/g3.113.005850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1534/g3.113.005850</ArticleId><ArticleId IdType="pmc">PMC3618356</ArticleId><ArticleId IdType="pubmed">23550139</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Erchia A.M., Gallo A., Manzari C., Raho S., Horner D.S., Chiara M., Valletti A., Aiello I., Mastropasqua F., Ciaccia L., et al. Massive transcriptome sequencing of human spinal cord tissues provides new insights into motor neuron degeneration in ALS. Sci. Rep. 2017;7:10046. doi: 10.1038/s41598-017-10488-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-10488-7</ArticleId><ArticleId IdType="pmc">PMC5577269</ArticleId><ArticleId IdType="pubmed">28855684</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung H., Yoon B.C., Holt C.E. Axonal mRNA localization and local protein synthesis in nervous system assembly, maintenance and repair. Nat. Rev. Neurosci. 2012;13:308&#x2013;324.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3682205</ArticleId><ArticleId IdType="pubmed">22498899</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith E.F., Shaw P.J., De Vos K.J. The role of mitochondria in amyotrophic lateral sclerosis. Neurosci. Lett. 2019;710:132933.</Citation><ArticleIdList><ArticleId IdType="pubmed">28669745</ArticleId></ArticleIdList></Reference><Reference><Citation>Karbowski M., Neutzner A. Neurodegeneration as a consequence of failed mitochondrial maintenance. Acta Neuropathol. 2011;123:157&#x2013;171.</Citation><ArticleIdList><ArticleId IdType="pubmed">22143516</ArticleId></ArticleIdList></Reference><Reference><Citation>Polymenidou M., Lagier-Tourenne C., Hutt K.R., Huelga S.C., Moran J., Liang T.Y., Ling S.C., Sun E., Wancewicz E., Mazur C., et al. Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat. Neurosci. 2011;14:459&#x2013;468. doi: 10.1038/nn.2779.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2779</ArticleId><ArticleId IdType="pmc">PMC3094729</ArticleId><ArticleId IdType="pubmed">21358643</ArticleId></ArticleIdList></Reference><Reference><Citation>Sephton C.F., Cenik C., Kucukural A., Dammer E.B., Cenik B., Han Y.H., Dewey C.M., Roth F.P., Herz J., Peng J., et al. Identification of neuronal RNA targets of TDP-43-containing ribonucleoprotein complexes. J. Biol. Chem. 2011;286:1204&#x2013;1215. doi: 10.1074/jbc.M110.190884.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.190884</ArticleId><ArticleId IdType="pmc">PMC3020728</ArticleId><ArticleId IdType="pubmed">21051541</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiga A., Ishihara T., Miyashita A., Kuwabara M., Kato T., Watanabe N., Yamahira A., Kondo C., Yokoseki A., Takahashi M., et al. Alteration of POLDIP3 splicing associated with loss of function of TDP-43 in tissues affected with ALS. PLoS ONE. 2012;7:e43120. doi: 10.1371/journal.pone.0043120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0043120</ArticleId><ArticleId IdType="pmc">PMC3416794</ArticleId><ArticleId IdType="pubmed">22900096</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang C., Wang H., Qiao T., Yang B., Aliaga L., Qiu L., Tan W., Salameh J., McKenna-Yasek D.M., Smith T., et al. Partial loss of TDP-43 function causes phenotypes of amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA. 2014;111:E1121&#x2013;E1129. doi: 10.1073/pnas.1322641111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1322641111</ArticleId><ArticleId IdType="pmc">PMC3970502</ArticleId><ArticleId IdType="pubmed">24616503</ArticleId></ArticleIdList></Reference><Reference><Citation>Mroczek S., Dziembowski A. U6 RNA biogenesis and disease association. Wiley Interdiscip. Rev. RNA. 2013;4:581&#x2013;592. doi: 10.1002/wrna.1181.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wrna.1181</ArticleId><ArticleId IdType="pubmed">23776162</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuiji H., Iguchi Y., Furuya A., Kataoka A., Hatsuta H., Atsuta N., Tanaka F., Hashizume Y., Akatsu H., Murayama S., et al. Spliceosome integrity is defective in the motor neuron diseases ALS and SMA. EMBO Mol. Med. 2013;5:221&#x2013;234. doi: 10.1002/emmm.201202303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/emmm.201202303</ArticleId><ArticleId IdType="pmc">PMC3569639</ArticleId><ArticleId IdType="pubmed">23255347</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishihara T., Ariizumi Y., Shiga A., Kato T., Tan C.F., Sato T., Miki Y., Yokoo M., Fujino T., Koyama A., et al. Decreased number of gemini of coiled bodies and U12 snRNA level in amyotrophic lateral sclerosis. Hum. Mol. Genet. 2013;22:4136&#x2013;4147. doi: 10.1093/hmg/ddt262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt262</ArticleId><ArticleId IdType="pubmed">23740936</ArticleId></ArticleIdList></Reference><Reference><Citation>Yahara M., Kitamura A., Kinjo M. U6 snRNA expression prevents toxicity in TDP-43-knockdown cells. PLoS ONE. 2017;12:e0187813. doi: 10.1371/journal.pone.0187813.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0187813</ArticleId><ArticleId IdType="pmc">PMC5681290</ArticleId><ArticleId IdType="pubmed">29125873</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y., Curle A.J., Haider A.M., Balmus G. The role of DNA damage response in amyotrophic lateral sclerosis. Essays Biochem. 2020;64:847&#x2013;861.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7588667</ArticleId><ArticleId IdType="pubmed">33078197</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Dharmalingam P., Vasquez V., Mitra J., Boldogh I., Rao K.S., Kent T.A., Mitra S., Hegde M.L. Chronic oxidative damage together with genome repair deficiency in the neurons is a double whammy for neurodegeneration: Is damage response signaling a potential therapeutic target? Mech. Ageing Dev. 2017;161:163&#x2013;176.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5316312</ArticleId><ArticleId IdType="pubmed">27663141</ArticleId></ArticleIdList></Reference><Reference><Citation>Barber S.C., Mead R.J., Shaw P.J. Oxidative stress in ALS: A mechanism of neurodegeneration and a therapeutic target. Biochim. Biophys. Acta- Mol. Basis Dis. 2006;1762:1051&#x2013;1067.</Citation><ArticleIdList><ArticleId IdType="pubmed">16713195</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill S.J., Mordes D.A., Cameron L.A., Neuberg D.S., Landini S., Eggan K., Livingston D.M. Two familial ALS proteins function in prevention/repair of transcription-associated DNA damage. Proc. Natl. Acad. Sci. USA. 2016;113:E7701&#x2013;E7709. doi: 10.1073/pnas.1611673113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1611673113</ArticleId><ArticleId IdType="pmc">PMC5137757</ArticleId><ArticleId IdType="pubmed">27849576</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitra J., Guerrero E.N., Hegde P.M., Liachko N.F., Wang H., Vasquez V., Gao J., Pandey A., Paul Taylor J., Kraemer B.C., et al. Motor neuron disease-associated loss of nuclear TDP-43 is linked to DNA double-strand break repair defects. Proc. Natl. Acad. Sci. USA. 2019;116:4696&#x2013;4705. doi: 10.1073/pnas.1818415116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1818415116</ArticleId><ArticleId IdType="pmc">PMC6410842</ArticleId><ArticleId IdType="pubmed">30770445</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerrero E.N., Mitra J., Wang H., Rangaswamy S., Hegde P.M., Basu P., Rao K.S., Hegde M.L. Amyotrophic lateral sclerosis-associated TDP-43 mutation Q331K prevents nuclear translocation of XRCC4-DNA ligase 4 complex and is linked to genome damage-mediated neuronal apoptosis. Hum. Mol. Genet. 2019;28:2459&#x2013;2476. doi: 10.1093/hmg/ddz062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddz062</ArticleId><ArticleId IdType="pmc">PMC6659010</ArticleId><ArticleId IdType="pubmed">31067307</ArticleId></ArticleIdList></Reference><Reference><Citation>Pal A., Gla&#xdf; H., Naumann M., Kreiter N., Japtok J., Sczech R., Hermann A. High content organelle trafficking enables disease state profiling as powerful tool for disease modelling. Sci. Data. 2018;5:180241. doi: 10.1038/sdata.2018.241.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sdata.2018.241</ArticleId><ArticleId IdType="pmc">PMC6233479</ArticleId><ArticleId IdType="pubmed">30422121</ArticleId></ArticleIdList></Reference><Reference><Citation>Lv J., Jiang S., Yang Z., Hu W., Wang Z., Li T., Yang Y. PGC-1&#x3b1; sparks the fire of neuroprotection against neurodegenerative disorders. Ageing Res. Rev. 2018;44:8&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">29580918</ArticleId></ArticleIdList></Reference><Reference><Citation>Prashantha Kumar B.R., Kumar A.P., Jose J.A., Prabitha P., Yuvaraj S., Chipurupalli S., Jeyarani V., Manisha C., Banerjee S., Jeyabalan J.B., et al. Minutes of PPAR-&#x3b3; agonism and neuroprotection. Neurochem. Int. 2020;140:104814.</Citation><ArticleIdList><ArticleId IdType="pubmed">32758586</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiaei M., Kipiani K., Chen J., Calingasan N.Y., Beal M.F. Peroxisome proliferator-activated receptor-gamma agonist extends survival in transgenic mouse model of amyotrophic lateral sclerosis. Exp. Neurol. 2005;191:331&#x2013;336. doi: 10.1016/j.expneurol.2004.10.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2004.10.007</ArticleId><ArticleId IdType="pubmed">15649489</ArticleId></ArticleIdList></Reference><Reference><Citation>Joardar A., Menzl J., Podolsky T.C., Manzo E., Estes P.S., Ashford S., Zarnescu D.C. PPAR gamma activation is neuroprotective in a Drosophila model of ALS based on TDP-43. Hum. Mol. Genet. 2014;24:1741&#x2013;1754. doi: 10.1093/hmg/ddu587.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu587</ArticleId><ArticleId IdType="pmc">PMC4381760</ArticleId><ArticleId IdType="pubmed">25432537</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodr&#xed;guez-Cueto C., Santos-Garc&#xed;a I., Garc&#xed;a-Toscano L., Espejo-Porras F., Bellido M., Fern&#xe1;ndez-Ruiz J., Mu&#xf1;oz E., de Lago E. Neuroprotective effects of the cannabigerol quinone derivative VCE-003.2 in SOD1G93A transgenic mice, an experimental model of amyotrophic lateral sclerosis. Biochem. Pharmacol. 2018;157:217&#x2013;226. doi: 10.1016/j.bcp.2018.07.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2018.07.049</ArticleId><ArticleId IdType="pubmed">30076846</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman M.R., Islam T., Turanli B., Zaman T., Faruquee H.M., Rahman M.M., Mollah M.N.H., Nanda R.K., Arga K.Y., Gov E., et al. Network-based approach to identify molecular signatures and therapeutic agents in Alzheimer&#x2019;s disease. Comput. Biol. Chem. 2019;78:431&#x2013;439. doi: 10.1016/j.compbiolchem.2018.12.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.compbiolchem.2018.12.011</ArticleId><ArticleId IdType="pubmed">30606694</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman M.R., Islam T., Zaman T., Shahjaman M., Karim M.R., Huq F., Quinn J.M.W., Holsinger R.M.D., Gov E., Moni M.A. Identification of molecular signatures and pathways to identify novel therapeutic targets in Alzheimer&#x2019;s disease: Insights from a systems biomedicine perspective. Genomics. 2020;112:1290&#x2013;1299. doi: 10.1016/j.ygeno.2019.07.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ygeno.2019.07.018</ArticleId><ArticleId IdType="pubmed">31377428</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinhardt P., Schmid B., Burbulla L.F., Sch&#xf6;ndorf D.C., Wagner L., Glatza M., H&#xf6;ing S., Hargus G., Heck S.A., Dhingra A., et al. Genetic correction of a lrrk2 mutation in human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expression. Cell Stem Cell. 2013;12:354&#x2013;367. doi: 10.1016/j.stem.2013.01.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2013.01.008</ArticleId><ArticleId IdType="pubmed">23472874</ArticleId></ArticleIdList></Reference><Reference><Citation>Xing Y., Yu T., Wu Y.N., Roy M., Kim J., Lee C. An expectation-maximization algorithm for probabilistic reconstructions of full-length isoforms from splice graphs. Nucleic Acids Res. 2006;34:3150&#x2013;3160. doi: 10.1093/nar/gkl396.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkl396</ArticleId><ArticleId IdType="pmc">PMC1475746</ArticleId><ArticleId IdType="pubmed">16757580</ArticleId></ArticleIdList></Reference><Reference><Citation>Casula M., Iyer A.M., Spliet W.G.M., Anink J.J., Steentjes K., Sta M., Troost D., Aronica E. Toll-like receptor signaling in amyotrophic lateral sclerosis spinal cord tissue. Neuroscience. 2011;179:233&#x2013;243. doi: 10.1016/j.neuroscience.2011.02.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2011.02.001</ArticleId><ArticleId IdType="pubmed">21303685</ArticleId></ArticleIdList></Reference><Reference><Citation>Mortazavi A., Williams B.A., McCue K., Schaeffer L., Wold B. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat. Methods. 2008;5:621&#x2013;628. doi: 10.1038/nmeth.1226.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.1226</ArticleId><ArticleId IdType="pubmed">18516045</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Zhou B., Pache L., Chang M., Khodabakhshi A.H., Tanaseichuk O., Benner C., Chanda S.K. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat. Commun. 2019;10:1523. doi: 10.1038/s41467-019-09234-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-09234-6</ArticleId><ArticleId IdType="pmc">PMC6447622</ArticleId><ArticleId IdType="pubmed">30944313</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuleshov M.V., Jones M.R., Rouillard A.D., Fernandez N.F., Duan Q., Wang Z., Koplev S., Jenkins S.L., Jagodnik K.M., Lachmann A., et al. Enrichr: A comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 2016;44:W90&#x2013;W97. doi: 10.1093/nar/gkw377.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkw377</ArticleId><ArticleId IdType="pmc">PMC4987924</ArticleId><ArticleId IdType="pubmed">27141961</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang D.W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 2009;4:44&#x2013;57. doi: 10.1038/nprot.2008.211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2008.211</ArticleId><ArticleId IdType="pubmed">19131956</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanehisa M., Sato Y., Kawashima M., Furumichi M., Tanabe M. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 2016;44:D457&#x2013;D462. doi: 10.1093/nar/gkv1070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkv1070</ArticleId><ArticleId IdType="pmc">PMC4702792</ArticleId><ArticleId IdType="pubmed">26476454</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou G., Soufan O., Ewald J., Hancock R.E.W., Basu N., Xia J. NetworkAnalyst 3.0: A visual analytics platform for comprehensive gene expression profiling and meta-analysis. Nucleic Acids Res. 2019;47:W234&#x2013;W241. doi: 10.1093/nar/gkz240.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkz240</ArticleId><ArticleId IdType="pmc">PMC6602507</ArticleId><ArticleId IdType="pubmed">30931480</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro-Mondragon J.A., Riudavets-Puig R., Rauluseviciute I., Berhanu Lemma R., Turchi L., Blanc-Mathieu R., Lucas J., Boddie P., Khan A., Perez N.M., et al. JASPAR 2022: The 9th release of the open-access database of transcription factor binding profiles. Nucleic Acids Res. 2021;50:D165&#x2013;D173. doi: 10.1093/nar/gkab1113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkab1113</ArticleId><ArticleId IdType="pmc">PMC8728201</ArticleId><ArticleId IdType="pubmed">34850907</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>